ARK Investment Management - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 139 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$2,895,000
+144.7%
183,094
+165.9%
0.11%
+79.7%
Q1 2018$1,183,000
+24.9%
68,854
+59.3%
0.06%
-21.3%
Q4 2017$947,000
+121.8%
43,215
+204.9%
0.08%
-9.6%
Q2 2017$427,000
+233.6%
14,174
+299.2%
0.08%
+124.3%
Q1 2017$128,000
-20.0%
3,551
+11.0%
0.04%
-36.2%
Q4 2016$160,0003,2000.06%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders